Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey M Dusheiko

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|August 22, 2009
Cost-effectiveness of oral treatments for chronic hepatitis BGeoffrey M Dusheiko
The International Journal of Biochemistry & Cell Biology|June 19, 2004
Hepatitis C and treatment with pegylated interferon and ribavirinJames Gotto, Geoffrey M Dusheiko
Expert Review of Anti-Infective Therapy|April 7, 2009
Perspectives on the management of chronic hepatitis B and CGeoffrey M Dusheiko, Michael Graham Jacobs
Lancet (London, England)|February 18, 2015
Hepatitis CDaniel P Webster, Paul Klenerman, Geoffrey M Dusheiko
Expert Opinion on Investigational Drugs|May 24, 2012
TMC435 for the treatment of chronic hepatitis CSudeep Tanwar, Paul M Trembling, Geoffrey M Dusheiko
Expert Review of Anti-Infective Therapy|March 9, 2012
Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infectionPaul M Trembling, Sudeep Tanwar, Geoffrey M Dusheiko
Lancet (London, England)|October 22, 2019
Hepatitis CC Wendy Spearman, Geoffrey M Dusheiko, Margaret Hellard, et al.
Nature Reviews. Gastroenterology & Hepatology|September 11, 2013
Treatment decisions and contemporary versus pending treatments for hepatitis CPaul M Trembling, Sudeep Tanwar, William M Rosenberg, et al.
European Journal of Gastroenterology & Hepatology|January 16, 2010
Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two casesMikio Kajihara, Sara Montagnese, Pooja Khanna, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2005
Optimal dosing frequency of pegylated interferon alfa-2b monotherapy for chronic hepatitis C virus infectionYoav Lurie, Regine Rouzier-Panis, George J M Webster, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|August 22, 2009
Cost-effectiveness of oral treatments for chronic hepatitis BGeoffrey M Dusheiko
The International Journal of Biochemistry & Cell Biology|June 19, 2004
Hepatitis C and treatment with pegylated interferon and ribavirinJames Gotto, Geoffrey M Dusheiko
Expert Review of Anti-Infective Therapy|April 7, 2009
Perspectives on the management of chronic hepatitis B and CGeoffrey M Dusheiko, Michael Graham Jacobs
Lancet (London, England)|February 18, 2015
Hepatitis CDaniel P Webster, Paul Klenerman, Geoffrey M Dusheiko
Expert Opinion on Investigational Drugs|May 24, 2012
TMC435 for the treatment of chronic hepatitis CSudeep Tanwar, Paul M Trembling, Geoffrey M Dusheiko
Expert Review of Anti-Infective Therapy|March 9, 2012
Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infectionPaul M Trembling, Sudeep Tanwar, Geoffrey M Dusheiko
Lancet (London, England)|October 22, 2019
Hepatitis CC Wendy Spearman, Geoffrey M Dusheiko, Margaret Hellard, et al.
Nature Reviews. Gastroenterology & Hepatology|September 11, 2013
Treatment decisions and contemporary versus pending treatments for hepatitis CPaul M Trembling, Sudeep Tanwar, William M Rosenberg, et al.
European Journal of Gastroenterology & Hepatology|January 16, 2010
Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two casesMikio Kajihara, Sara Montagnese, Pooja Khanna, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2005
Optimal dosing frequency of pegylated interferon alfa-2b monotherapy for chronic hepatitis C virus infectionYoav Lurie, Regine Rouzier-Panis, George J M Webster, et al.
Pageof 3